| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Ling Ping Tao CEO | SSE Exchange | CNE1000022R8 ISIN |
| CN Country | 475 Employees | 5 Jul 2022 Last Dividend | 10 May 2018 Last Split | - IPO Date |
Lionco Pharmaceutical Group Co., Ltd. is a prominent entity in the pharmaceutical industry within China, focusing on the research, development, production, and commercialization of a wide range of pharmaceutical products. Since its inception in 2003, the company has committed itself to addressing various healthcare needs through its diverse product portfolio. With its headquarters located in Shannan, China, Lionco Pharmaceutical Group has successfully established itself as a key player in the pharmaceutical sector, leveraging its extensive network of subsidiaries to enhance its market presence and deliver innovative healthcare solutions across the nation.